Bio-Rad Laboratories BIO Clinical Diagnostics — Goodwill, net
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Bio-Rad Laboratories in its filing.
Tagged under the XBRL concept us-gaap:Goodwill.
The official record: Bio-Rad Laboratories’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Bio-Rad Laboratories's clinical diagnostics — goodwill, net.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Bio-Rad Laboratories's clinical diagnostics — goodwill, net?
- Bio-Rad Laboratories (BIO) reported clinical diagnostics — goodwill, net of $128.4M in Q1 2026.
- How has Bio-Rad Laboratories's clinical diagnostics — goodwill, net changed year-over-year?
- Bio-Rad Laboratories's clinical diagnostics — goodwill, net increased by 4.3% year-over-year, from $123.1M to $128.4M.
- What is the long-term trend for Bio-Rad Laboratories's clinical diagnostics — goodwill, net?
- Over 4 years (2021 to 2025), Bio-Rad Laboratories's clinical diagnostics — goodwill, net has grown at a 22.8% compound annual growth rate (CAGR), from $223.2M to $507.2M.
- What does clinical diagnostics — goodwill, net mean?
- The net carrying amount of goodwill for the Clinical Diagnostics segment after accounting for all historical impairment losses. This represents the residual value of intangible assets that provide competitive advantages not separately identifiable.